[Comment] The next step towards lower complication rates in fetal therapy for congenital diaphragmatic hernia

Phase 1positiveSmart tracheal occlusion (Smart-TO) devicePositive

AI Analysis

Summary

Russo and colleagues report the first-in-human phase 1 study of the Smart tracheal occlusion (Smart-TO) device, a potentially practice-changing refinement in fetoscopic endoluminal tracheal occlusion for treating moderate or severe congenital diaphragmatic hernia. The device features non-invasive reversal of tracheal occlusion through magnetic-field-induced balloon deflation.

Clinical Trial Data

Phase

Outcome Details

First-in-human phase 1 study of Smart-TO device for fetoscopic endoluminal tracheal occlusion with magnetic-field-induced balloon deflation

Importance:6/10

Sentiment:

0.70

fetal therapycongenital diaphragmatic herniamedical devicephase 1fetoscopic intervention

Related Companies

$TRAX

Read the original article

Published by The Lancet on June 23, 2026 10:30 PM

Read Original